Diprovocim-1

Diprovocim-1 is a potent TLR1/2 agonist that stimulates TNF-α release in THP-1 cells and enhances antigen-specific IgG1 production in vivo. It acts as an effective vaccine adjuvant and synergizes with anti-PD-L1 therapy to promote cytotoxic T cell activity, reducing tumor growth in melanoma models.

Product Specifications

CAS Number

2170867-89-5

Field of Research

Cell Biology, Immunology & Inflammation, Signal Transduction

Purity

99.64% (May vary between batches)

Smiles

N (C (=O) [C@H]1[C@H] (C (N[C@@H]2[C@H] (C2) C3=CC=CC=C3) =O) CN (C (=O) C4=CC=C (C (=O) N5C[C@@H] (C (N[C@@H]6[C@H] (C6) C7=CC=CC=C7) =O) [C@H] (C (N[C@@H]8[C@H] (C8) C9=CC=CC=C9) =O) C5) C=C4) C1) [C@@H]%10[C@H] (C%10) C%11=CC=CC=C%11